EUVIMEDEUVIMED entdecken
Metaanalyse

Probiotic Supplement for the Prevention of Gestational Diabetes: A Meta-Analysis of Randomized Controlled Trials

Zengliang Zhang, Renxiu Niu, Huixin Zhang, Teng Ma, Xuexia Chen, Linlin Pan

Zeitschrift für Geburtshilfe und Neonatologie · 01.02.2023 · 227 (01) · 24-30

DOI: 10.1055/a-1956-3927 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Zeitschrift für Geburtshilfe und Neonatologie, erschienen am 01.02.2023. Verfasst von Zengliang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Traditinal Chinese Medicine College, Inner Mongolia Medical University, Jinshan Economic & Technology Development Zone, Hohhot, Inner Mongolia, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Probiotics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Probiotic supplements may have some potential in preventing gestational diabetes, and this meta-analysis aims to explore the efficacy of probiotic supplements to prevent gestational diabetes.

Methods

PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases were systematically searched, and we included randomized controlled trials (RCTs) assessing the effect of probiotic supplements on the incidence of gestational diabetes mellitus. Meta-analysis was performed using the fixed-effect or random-effect model as appropriate.

Results

Six RCTs were finally included in the meta-analysis. Overall, compared with control intervention in pregnant women, probiotic supplementation intervention showed no obvious impact on the incidence of gestational diabetes (OR=0.68; 95% CI=0.39 to 1.20; P=0.18), fasting plasma glucose (SMD=−0.05; 95% CI=−0.29 to 0.19; P=0.69), 2 h-OGTT (SMD=−0.07; 95% CI=−0.27 to 0.13; P=0.47), gestational age (SMD=0.04; 95% CI=−0.14 to 0.21; P=0.69) or preeclampsia (OR=1.22; 95% CI=0.83 to 1.78; P=0.31).

Conclusions

Probiotic supplementation was confirmed to have no benefits for the prevention of gestational diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalProbioticsFemaleHumansPregnancyDietary SupplementsGestational AgeRandomized Controlled Trials as Topic

Autor:innen und Institutionen

  • Traditinal Chinese Medicine College, Inner Mongolia Medical University, Jinshan Economic & Technology Development Zone, Hohhot, Inner Mongolia, China.
  • Nursing School of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • Department of Traumatology of the Second Affiliated Hospital of Innmer Mongolia Medical University, Hohhot, Inner Mongolia, China.

Zitieren

APA

Zhang, Z., Niu, R., Zhang, H., Ma, T., Chen, X., & Pan, L. (2023). Probiotic Supplement for the Prevention of Gestational Diabetes: A Meta-Analysis of Randomized Controlled Trials. Zeitschrift für Geburtshilfe und Neonatologie, 227(01), 24-30. https://doi.org/10.1055/a-1956-3927

Vancouver

Zhang Z, Niu R, Zhang H, Ma T, Chen X, Pan L. Probiotic Supplement for the Prevention of Gestational Diabetes: A Meta-Analysis of Randomized Controlled Trials. Zeitschrift für Geburtshilfe und Neonatologie. 2023;227(01):24-30. doi:10.1055/a-1956-3927

BibTeX
@article{Zhang2023,
  author = {Zhang, Zengliang and Niu, Renxiu and Zhang, Huixin and Ma, Teng and Chen, Xuexia and Pan, Linlin},
  title = {Probiotic Supplement for the Prevention of Gestational Diabetes: A Meta-Analysis of Randomized Controlled Trials},
  journal = {Zeitschrift für Geburtshilfe und Neonatologie},
  year = {2023},
  volume = {227},
  number = {01},
  pages = {24--30},
  doi = {10.1055/a-1956-3927}
}
Kostenlos starten →